Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Engineering complement activation on polypropylene sulfide vaccine nanoparticles.

Susan N Thomas1, André J van der Vlies, Conlin P O'Neil

  • 1Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Station 15, Lausanne CH 1015, Switzerland.

Biomaterials
|December 25, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Composite biomaterials of polyelectrolyte complex micelle nanoparticles in hyaluronic acid gels enable local, targeted miR-92a inhibition and enhanced angiogenesis in diabetic wound repair.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Corrigendum to 'Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant' [Biomaterials, 128 (2021), 121159].

Biomaterials·2026
Same author

Serum albumin-fused interleukin-10 prevents neuroinflammation by promoting immunoregulation in the secondary lymphoid organs and limiting immune cell infiltration in the spinal cord.

bioRxiv : the preprint server for biology·2026
Same author

Thermogelation of polymer nanoassemblies: promising platforms for injectable biomaterials in medical applications.

Nanomedicine (London, England)·2026
Same author

Probing Cellular Activity Via Charge-Sensitive Quantum Nanoprobes.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Precision mRNA Nanomedicine for Targeted Vascular Therapies in ARDS and Atherosclerosis.

bioRxiv : the preprint server for biology·2026
Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026
Same journal

Mg-integrated octopus-inspired hydrogel dressing enables autonomous adhesion and wound closure for enhanced healing via sequential microenvironment regulation.

Biomaterials·2026
Same journal

Engineering miRNA-223 nanocomplexes via bioorthogonal self-assembly for precision therapy of intervertebral disc degeneration.

Biomaterials·2026
Same journal

Corrigendum to "Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide" [Biomaterials 42 (2015) 16442].

Biomaterials·2026
Same journal

An injectable Ce-MnCo LDH nanozyme gel with cascade catalytic activity for acute radiation proctitis in rats.

Biomaterials·2026
Same journal

Peptide coacervate-mediated siRNA delivery for dual PD-1/PD-L1 blockade to enhance colorectal cancer immunotherapy.

Biomaterials·2026
See all related articles

Designing nanoparticle surface chemistry controls complement activation for immunotherapeutics. Modulating NP surfaces influences complement deposition, impacting immune responses and offering a new strategy for vaccine development.

Area of Science:

  • Immunology
  • Biomaterials Science
  • Nanotechnology

Background:

  • The complement system regulates innate and adaptive immunity, making it a target for immunotherapeutics.
  • Nanoparticles (NPs) are being explored as a vaccine platform, particularly those that activate complement.
  • Controlling complement activation on NP surfaces is crucial for effective immunotherapeutic applications.

Purpose of the Study:

  • To investigate how NP surface chemistry modulates complement deposition (active or inactive forms).
  • To explore the relationship between NP surface functionalization and in vivo immune responses.
  • To understand the mechanisms controlling complement protein C3 stability on NP surfaces.

Main Methods:

  • Synthesized polypropylene sulfide core, block copolymer Pluronic corona NPs with varying surface chemistries (nucleophile-containing, carboxylated, hydroxylated).

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Published on: September 1, 2023

Related Experiment Videos

Last Updated: Jun 5, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Published on: September 1, 2023

  • Exposed NPs to serum to assess complement activation and C3 deposition via the alternative pathway.
  • Quantified C3b and iC3b deposition and retention on NP surfaces.
  • Evaluated in vivo antigen-specific immune responses (antibody production, T cell proliferation, IFN-γ production).
  • Assessed NP affinity to factor H.

    • Main Results:

    • Nucleophile-containing NP surfaces activated complement and underwent in situ C3 functionalization via the alternative pathway.
    • Carboxylated NPs showed higher C3b deposition and retention compared to hydroxylated NPs.
    • Deposited C3b on hydroxylated NPs was more significantly inactivated to iC3b.
    • In situ NP functionalization correlated with enhanced antigen-specific immune responses.
    • C3b inactivation to iC3b did not correlate with factor H affinity, suggesting other architectural factors control C3 stability.

    Conclusions:

    • NP surface chemistry design can effectively control biomaterial-associated complement activation.
    • Modulating NP surface chemistry offers a strategy to fine-tune complement deposition for immunotherapeutic applications.
    • Understanding complement-biomaterial interactions is key to developing advanced vaccine platforms and immunotherapies.